Scarica l'app Stockscreener
3.60
2.30%
0.12
Precedente Chiudi:
$3.48
Aprire:
$3.52
Volume 24 ore:
14,341
Relative Volume:
0.02
Capitalizzazione di mercato:
$437.53M
Reddito:
$433.14M
Utile/perdita netta:
$4.95M
Rapporto P/E:
100.84
EPS:
0.0357
Flusso di cassa netto:
$6.55M
1 W Prestazione:
-6.32%
1M Prestazione:
+14.84%
6M Prestazione:
+43.55%
1 anno Prestazione:
+11.25%
Intervallo 1D:
$3.52
$3.60
Intervallo di 1 settimana:
$3.40
$3.85
Portata 52W:
$2.165
$4.57
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Nome
Organogenesis Holdings Inc
Settore
Telefono
781-575-0775
Indirizzo
85 DAN ROAD, CANTON, MA
Confronta ORGO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.585 | 437.53M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
172.94 | 77.71B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.585 | 43.05B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.36 | 42.23B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.34 | 19.33B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
151.85 | 15.43B | 2.24B | 385.90M | 440.10M | 3.73 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Iniziato | Lake Street | Buy |
| 2024-02-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-08-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Iniziato | SVB Leerink | Outperform |
| 2019-08-26 | Ripresa | Credit Suisse | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
| 2019-04-17 | Iniziato | Oppenheimer | Outperform |
| 2019-04-11 | Iniziato | SunTrust | Buy |
Mostra tutto
Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie
A Look At Organogenesis Holdings Inc (ORGO) Stock Performance - Stocks Register
JPMorgan Chase & Co. Increases Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by JPMorgan Chase & Co. - Defense World
Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025 - The Manila Times
Organogenesis to Report Q4 and Full Year 2024 Financial Results on February 27 - StockTitan
Organogenesis (ORGO) Stock Price, News & Analysis - MarketBeat
Analysts Issue Forecasts for Organogenesis FY2025 Earnings - Defense World
Analysts Offer Predictions for Organogenesis FY2025 Earnings - MarketBeat
Barclays PLC Acquires 67,855 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Assenagon Asset Management S.A. Has $9.44 Million Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Assenagon Asset Management S.A. Purchases 1,035,120 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Leads These 3 US Penny Stocks - Simply Wall St
Jane Street Group LLC Lowers Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Boosted by Barclays PLC - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by State Street Corp - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Up 29.1% in December - MarketBeat
Organogenesis signs Smithfield lease with subsidies in hand - The Business Journals
Fmr LLC Buys 44,199 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Commerce Corp. grants tax agreement to Smithfield - Providence Business News
Gary S. Gillheeney Sells 5,585 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) CEO Gary S. Gillheeney Sells 55,615 Shares - MarketBeat
Organogenesis CEO Gary Gillheeney sells shares worth $206,358 - Investing.com
US Penny Stocks To Consider In December 2024 - Simply Wall St
Charles Schwab Investment Management Inc. Grows Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by Verition Fund Management LLC - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Position Cut by BNP Paribas Financial Markets - Defense World
Organogenesis CEO Gary Gillheeney sells shares worth $940,066 - Investing.com
Organogenesis CEO Gary Gillheeney sells shares worth $940,066 By Investing.com - Investing.com UK
Wound Care Market 2024By Industry Outlook, Future Trends, - openPR
Organogenesis CEO Gillheeney sells shares worth $211,721 - Investing.com India
Organogenesis CEO Gillheeney sells shares worth $211,721 By Investing.com - Investing.com Nigeria
Jacobs Levy Equity Management Inc. Lowers Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc (NASDAQ: ORGO) -0.26% Decline Turns Investors Away - Stocks Register
Organogenesis Holdings Inc. announces an Equity Buyback for 500,000 shares, for $2.03 million. - Marketscreener.com
Organogenesis announces stock repurchase at trailing average price By Investing.com - Investing.com Australia
Organogenesis announces stock repurchase at trailing average price - Investing.com
Advantage Alpha Capital Partners LP Trims Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Mass. firm signs lease for former Rubius facility in Smithfield - Providence Business News
News | Massachusetts-based regenerative tissue medical firm expands in Rhode Island - CoStar Group
News | Massachusetts-based regenerative medical firm expands in Rhode Island - CoStar Group
Organogenesis Expands Manufacturing Capacity to Support Future Growth - The Manila Times
Organogenesis Holdings Inc. Expands Manufacturing Capacity to Support Future Growth - Marketscreener.com
Organogenesis Secures 122,000 Sq Ft Biomanufacturing Facility in Major Expansion | ORGO Stock News - StockTitan
Organogenesis Holdings Inc. Appoints Garrett Lustig to the Board - Marketscreener.com
Analysts Set Expectations for Organogenesis FY2024 Earnings - Defense World
Organogenesis Holdings’ $130 Million Private Placement Offering of Series A Convertible Preferred Stock - Global Legal Chronicle
FY2024 EPS Estimates for Organogenesis Boosted by Analyst - MarketBeat
Organogenesis (NASDAQ:ORGO) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Organogenesis Commends Final LCDs - The Manila Times
Organogenesis Holdings Inc Azioni (ORGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):